Texas A&M Football

Ask Liucci, Part 2: State of the Aggie defense, slowing the Kyles at Kyle & more

Billy Liucci answers another round of subscriber questions ranging from recruiting to day-to-day updates on the Aggies. This week, Liucci discusses how to address the Aggies' defensive woes, how A&M needs to slow Florida offense this weekend and much, much more.
By Billy Liucci
October 7, 2020
9.0k Views
Discuss
Story Poster
Photo by Craig Bisacre/Texas A&M Athletics
Where's Demond Demas!?

I thought we'd see more of him last week and we did. However, he did see just a couple of plays as opposed to zero.

He did some nice things in practice this week on their first full day (Tuesday). Mond and the offense had probably their best day of the fall (guys...don't you DARE do either of the things you're tempted to do here haha), so that's encouraging.

To continue reading, you must be a TexAgs Premium subscriber.
Get Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Jeff Banks Mike Elko Elijah Robinson Offensive Line Kyle Field Dan Mullen Ed Orgeron Jimbo Fisher Lincoln Riley Kyle Trask K.J. Costello Kyle Pitts
Show All
Ask Liucci Texas A&M vs. Florida Antonio Johnson Anthony Hines Jaylon Jones Kellen Mond Clifford Chattman Devin Morris Braedon Mowry DeMarvin Leal Erick Young Ainias Smith Demond Demas Andre White Fadil Diggs Haynes King Zach Calzada Moose Muhammad III Antonio Doyle Chris Russell Donell Harris Brian George Edgerrin Cooper Bryce Foster Tywone Malone Football Football Recruiting Texas A&M Oklahoma Texas Florida Ohio State Alabama 2020 2021
More Football
See All →
TexAgs Overtime: Comparing A&M's resume to other contenders
By Billy Liucci
Lunch with Liucci: Billy Liucci joins TexAgs Live (Monday, November 10)
By Billy Liucci
TexAgs Rewind (11/10)
By TexAgs Live
Daymion Sanford named SEC's Co-Defensive Player of the Week
By Richard Zane
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.